2021 ESC/EACTS Guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the …
A Vahanian, F Beyersdorf, F Praz… - European heart …, 2022 - academic.oup.com
Health professionals are encouraged to take the ESC/EACTS Guidelines fully into account
when exercising their clinical judgment, as well as in the determination and the …
when exercising their clinical judgment, as well as in the determination and the …
Time for practical clinical tools
D Katritsis - Arrhythmia & Electrophysiology Review, 2017 - ncbi.nlm.nih.gov
2. Philip Saul J, Kanter RJ, Writing Committee, et al. PACES/HRS expert consensus
statement on the use of catheter ablation in children and patients with congenital heart …
statement on the use of catheter ablation in children and patients with congenital heart …
[PDF][PDF] 2017 ESC/EACTS Guidelines for the management of valvular heart disease
H Baumgartner, V Falk, JJ Bax… - Polish Heart …, 2018 - journals.viamedica.pl
Recenzenci dokumentu: Marco Roffi, koordynator recenzji ze strony CPG (Szwajcaria),
Ottavio Alfieri1, koordynator recenzji ze strony EACTS (Włochy), Stefan Agewall (Norwegia) …
Ottavio Alfieri1, koordynator recenzji ze strony EACTS (Włochy), Stefan Agewall (Norwegia) …
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy …
Guidelines, Aspirin, Clopidogrel, Ticagrelor, Prasugrel, Dual antiplatelet therapy, Acute
coronary syndromes, Coronary artery bypass grafting, Coronary artery disease, Drug-eluting …
coronary syndromes, Coronary artery bypass grafting, Coronary artery disease, Drug-eluting …
JCS/JSCS/JATS/JSVS 2020 guidelines on the management of valvular heart disease
C Izumi, K Eishi, K Ashihara, T Arita, Y Otsuji… - Circulation …, 2020 - jstage.jst.go.jp
The “Guidelines on the Management of Valvular Heart Disease” were initially published as
the “Guidelines on Non-pharmacological Treatment of Valvular Heart Disease” in 2002 …
the “Guidelines on Non-pharmacological Treatment of Valvular Heart Disease” in 2002 …
[PDF][PDF] 2017 ESC/EACTS Guidelines for the management of valvular heart disease
V Falk, H Baumgartner, JJ Bax… - European Journal of …, 2017 - academic.oup.com
Health professionals are encouraged to take the ESC/EACTS Guidelines fully into account
when exercising their clinical judgment, as well as in the determination and the …
when exercising their clinical judgment, as well as in the determination and the …
National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the diagnosis and management of atrial …
D Brieger, J Amerena, JR Attia… - Medical Journal of …, 2018 - Wiley Online Library
Introduction: Atrial fibrillation (AF) is increasing in prevalence and is associated with
significant morbidity and mortality. The optimal diagnostic and treatment strategies for AF are …
significant morbidity and mortality. The optimal diagnostic and treatment strategies for AF are …
Asia-Pacific working group consensus on non-variceal upper gastrointestinal bleeding: an update 2018
Non-variceal upper gastrointestinal bleeding remains an important emergency condition,
leading to significant morbidity and mortality. As endoscopic therapy is the'gold standard'of …
leading to significant morbidity and mortality. As endoscopic therapy is the'gold standard'of …
Meta-analysis of reversal agents for severe bleeding associated with direct oral anticoagulants
A Gómez-Outes, P Alcubilla, G Calvo-Rojas… - Journal of the American …, 2021 - jacc.org
Abstract Background Direct oral anticoagulants (DOACs) have shown a positive benefit-risk
balance in both clinical trials and real-world data, but approximately 2% to 3.5% of patients …
balance in both clinical trials and real-world data, but approximately 2% to 3.5% of patients …
Antiplatelet agents for the treatment and prevention of coronary atherothrombosis
Antiplatelet drugs provide first-line antithrombotic therapy for the management of acute
ischemic syndromes (both coronary and cerebrovascular) and for the prevention of their …
ischemic syndromes (both coronary and cerebrovascular) and for the prevention of their …